These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32920126)

  • 1. Tumor microenvironment conditions that favor vessel co-option in colorectal cancer liver metastases: A theoretical model.
    Rada M; Lazaris A; Kapelanski-Lamoureux A; Mayer TZ; Metrakos P
    Semin Cancer Biol; 2021 Jun; 71():52-64. PubMed ID: 32920126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vessel co-option in glioblastoma: emerging insights and opportunities.
    Seano G; Jain RK
    Angiogenesis; 2020 Feb; 23(1):9-16. PubMed ID: 31679081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.
    Haas G; Fan S; Ghadimi M; De Oliveira T; Conradi LC
    Front Cell Dev Biol; 2021; 9():612774. PubMed ID: 33912554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
    Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
    J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases.
    Rada M; Kapelanski-Lamoureux A; Petrillo S; Tabariès S; Siegel P; Reynolds AR; Lazaris A; Metrakos P
    Commun Biol; 2021 Aug; 4(1):950. PubMed ID: 34376784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular mechanisms underlying neutrophil infiltration in vessel co-opting colorectal cancer liver metastases.
    Rada M; Hassan N; Lazaris A; Metrakos P
    Front Oncol; 2022; 12():1004793. PubMed ID: 36330498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
    Fleischer JR; Schmitt AM; Haas G; Xu X; Zeisberg EM; Bohnenberger H; Küffer S; Teuwen LA; Karras PJ; Beißbarth T; Bleckmann A; Planque M; Fendt SM; Vermeulen P; Ghadimi M; Kalucka J; De Oliveira T; Conradi LC
    Mol Cancer; 2023 Jan; 22(1):17. PubMed ID: 36691028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological features of vessel co-option versus sprouting angiogenesis.
    Latacz E; Caspani E; Barnhill R; Lugassy C; Verhoef C; Grünhagen D; Van Laere S; Fernández Moro C; Gerling M; Dirix M; Dirix LY; Vermeulen PB
    Angiogenesis; 2020 Feb; 23(1):43-54. PubMed ID: 31655928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy.
    Palmieri V; Lazaris A; Mayer TZ; Petrillo SK; Alamri H; Rada M; Jarrouj G; Park WY; Gao ZH; McDonald PP; Metrakos P
    J Pathol; 2020 Jun; 251(2):213-223. PubMed ID: 32297656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
    Frentzas S; Simoneau E; Bridgeman VL; Vermeulen PB; Foo S; Kostaras E; Nathan M; Wotherspoon A; Gao ZH; Shi Y; Van den Eynden G; Daley F; Peckitt C; Tan X; Salman A; Lazaris A; Gazinska P; Berg TJ; Eltahir Z; Ritsma L; Van Rheenen J; Khashper A; Brown G; Nystrom H; Sund M; Van Laere S; Loyer E; Dirix L; Cunningham D; Metrakos P; Reynolds AR
    Nat Med; 2016 Nov; 22(11):1294-1302. PubMed ID: 27748747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases.
    Rada M; Krzywon L; Petrillo S; Lazaris A; Metrakos P
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3.
    Rada M; Kapelanski-Lamoureux A; Tsamchoe M; Petrillo S; Lazaris A; Metrakos P
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
    Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
    Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies.
    Lazaris A; Amri A; Petrillo SK; Zoroquiain P; Ibrahim N; Salman A; Gao ZH; Vermeulen PB; Metrakos P
    J Pathol Clin Res; 2018 Jul; 4(3):184-192. PubMed ID: 29654716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vessel co-option and resistance to anti-angiogenic therapy.
    Kuczynski EA; Reynolds AR
    Angiogenesis; 2020 Feb; 23(1):55-74. PubMed ID: 31865479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the renin-angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver.
    Koh SL; Ager EI; Costa PL; Malcontenti-Wilson C; Muralidharan V; Christophi C
    Clin Exp Metastasis; 2014 Apr; 31(4):395-405. PubMed ID: 24442969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin1 Deficiency in Hepatocytes Affects the Growth of Colorectal Cancer Liver Metastases (CRCLM).
    Ibrahim NS; Lazaris A; Rada M; Petrillo SK; Huck L; Hussain S; Ouladan S; Gao ZH; Gregorieff A; Essalmani R; Seidah NG; Metrakos P
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.
    Stessels F; Van den Eynden G; Van der Auwera I; Salgado R; Van den Heuvel E; Harris AL; Jackson DG; Colpaert CG; van Marck EA; Dirix LY; Vermeulen PB
    Br J Cancer; 2004 Apr; 90(7):1429-36. PubMed ID: 15054467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microenvironment and colorectal liver metastases angiogenesis: surgical implications].
    Lim C; Eveno C; Pocard M
    Bull Cancer; 2013 Apr; 100(4):343-50. PubMed ID: 23532039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular and molecular components involved in pre-metastatic niche formation in colorectal cancer liver metastasis.
    Yang L; Li T; Shi H; Zhou Z; Huang Z; Lei X
    Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):389-399. PubMed ID: 33174441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.